Nicotinyl methylamide
Names | |
---|---|
Preferred IUPAC name N-Methylpyridine-3-carboxamide | |
Other names N-Methylnicotinamide; N-Methylniacinamide | |
Identifiers | |
3D model (JSmol) | |
Abbreviations | NAN[citation needed] |
ChEBI | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.003.679 |
EC Number |
|
MeSH | C008472 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C7H8N2O | |
Molar mass | 136.154 g·mol−1 |
Pharmacology | |
A05AB01 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Nicotinyl methylamide is an experimental drug with no approved indication.[1] It is also a metabolite of nicotinamide (vitamin B3) and is found in urine.[2]
See also
[edit]References
[edit]- ^ "N-methylnicotinamide". DrugBank.
- ^ "Nicotinyl methylamide". Inxight Drugs. National Center for Advancing Translational Sciences.